Healthy Living/WellnessGout Drug Lesinurad By AstraZeneca Receives Approval Recommendation From FDA Advisory Committee Lesinurad is a step closer towards achieving FDA approval as the agency’s Arthritis Advisory Committee has recommended that the drug be approved for use in the U.S.by Dianne Depra
Healthy Living/WellnessFDA Gives AstraZeneca Brilinta Nod Of Approval For Longer-Term Useby Dianne Depra
Healthy Living/WellnessAstraZeneca To Pay Inovio $727.5 Million For Experimental Cancer Drugby Rhodi Lee
Healthy Living/WellnessAstraZeneca-Lilly Collaboration To Test New Combination Of Cancer Drugsby Dianne Depra
Healthy Living/WellnessAstraZeneca Heart Drug Brilinta May Benefit Heart Patients But Carries Risksby James Maynard
Healthy Living/WellnessFDA approves AstraZeneca's EPANOVA, adjunct to diet for people with very high triglyceride levelsby Anne Francis